News
The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...
TipRanks on MSN19h
Sarepta price target lowered to $30 from $84 at JPMorganJPMorgan lowered the firm’s price target on Sarepta (SRPT) to $30 from $84 and keeps an Overweight rating on the shares. The firm made changes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback